Oral Oncology
Volume 37, Issue 6 , Pages 498-504 , September 2001

Inactivation of the p14ARF, p15INK4B and p16INK4A genes is a frequent event in human oral squamous cell carcinomas

Received 7 November 2000 ,Accepted 29 November 2000.

References 

  1. Chin L, Pomerantz J, Depinho RA. The INK4a/ARF tumor suppressor (one gene–two products–two pathways). Trends Biochem. Sci. 1998;23:291–296
  2. Sherr CJ. G1 phase progression (cycling on cue). Cell. 1994;79:551–555
  3. Morgan DO. Principles of CDK regulation. Nature. 1995;374:131–134
  4. Pomerantz J, Schreiber agus N, Lieos NJ, Silverman A, Alland L, Chin L, et al.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 1998;92:713–723
  5. Serraono M, Lin AW, Mccurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88:593–602
  6. Palmero I, Pantoja C, Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature. 1998;395:125–126
  7. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, et al.  p14ARF links the tumour suppressors RB and p53. Nature. 1998;395:124–125
  8. Serraono M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704–707
  9. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994;371:257–261
  10. Herman JG, Jen J, Merlo A, Baylin SB. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 1996;56:722–727
  11. Naeroz H, Van Der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 1994;54:1152–1155
  12. Boyle JO, Hakim J, Koch W, Van Der Riet P, Hruban RH, Roa RA, et al.  The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993;53:4477–4480
  13. Gonzales MV, Pello MF, Lopez-Larrea C, Squarez C, Menendez NJ, Coto E. Loss of heterozygosity and mutation analysis of the p16(9p21) and p53(17p13) genes in squamous cell carcinoma of the head and neck. Clin Cancer Res. 1994;1:1043–1049
  14. Van Der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, et al.  Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 1994;54:1156–1158
  15. Kamb A. Cyclin-dependent kinase inhibitors and human cancer. Curr Top Microbiol Immunol. 19987;227;139-148
  16. Kamijo T, Zindy F, Roussel MF, Qulle DE, Doening JR, Ashmun RA, et al.  Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 1997;91:649–659
  17. Gardie B, Cayuela JM, Martini S, Siguax F. Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia. Blood. 1998;91:1016–1020
  18. Larsen CJ. p16INK4a (a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression). Oncogene. 1996;12:2041–2044
  19. Sangfelt O, Erinckson S, Einhorn S, Grander D. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines. Oncogene. 1997;14:415–423
  20. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, et al.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 1996;56:3630–3633
  21. Riese U, Dahse R, Fiedler W, Theuer C, Koscielny S, Ernst G, et al.  Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer. Int J Mol Med. 41999;61-65:
  22. Yarbrough WG, Buckmire RA, Bessho M, Liu ET. Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors. J Natl Cancer Inst. 1999;91:1569–1574
  23. Syeling L, Adel K, Ei-Naggar . Differential expression of key cell cycle genes (p16/cyclinD1/pRb) in head and neck squamous cell carcinoma. Lab Invest. 1999;79:255–260
  24. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, et al.  Complex structure and regulation of the p16 (MTS1) locus. Cancer Res. 1995;55:2988–2994

PII: S1368-8375(00)00142-1

Oral Oncology
Volume 37, Issue 6 , Pages 498-504 , September 2001

Article Tools

* Image Usage & Resolution